Abnormal intracellular Ca2+ homeostasis and disease

Cell Calcium

Volumn 28, Issue 1, 2000, Pages 1-21

  Missiaen, L ^a   Robberecht, W ^a   Van Den Bosch, L ^a   Callewaert, G ^a   Parys, J B ^a   Wuytack, F ^a   Raeymaekers, L ^a   Nilius, B ^a   Eggermont, J ^a   De Smedt, H ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ANTIBODY; CALCIUM CHANNEL; CALCIUM ION; DIHYDROPYRIDINE; IMMUNOSUPPRESSIVE AGENT; INOSITOL TRISPHOSPHATE; RECEPTOR; RYANODINE RECEPTOR; SODIUM CALCIUM EXCHANGE PROTEIN;

ANIMAL MODEL; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL FUNCTION; CELL ORGANELLE; CEREBELLAR ATAXIA; CONCENTRATION (PARAMETERS); CYTOLOGY; CYTOSOL; DARIER DISEASE; EATON LAMBERT SYNDROME; EPILEPSY; EXTRACELLULAR SPACE; HAILEY HAILEY DISEASE; HAIR CELL; HEART; HUMAN; HYPOKALEMIC PERIODIC PARALYSIS; IN VITRO STUDY; KERATINOCYTE; MALIGNANT HYPERTHERMIA; MANIC DEPRESSIVE PSYCHOSIS; MIGRAINE; MOUSE; MUSCLE MALFORMATION; MUSCULOSKELETAL DISEASE; MUTATION; NONHUMAN; PATHOPHYSIOLOGY; PHOTORECEPTOR; PHYSICAL DISEASE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SODIUM CALCIUM EXCHANGE; STRESS; VISUAL DISORDER;

ANIMALIA; ATAXIA; SUIDAE;

EID: 0033830548     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1054/ceca.2000.0131     Document Type: Review

References (249)

1. Inositol trisphosphate and calcium signalling
2. Calcium channelopathies
3. Transient receptor potential channels as molecular substrates of receptor-mediated cation entry
4. A model for receptor-regulated calcium entry
5. 2+ influx
6. 2+ entry by inositol phosphates-a possible mechanism
7. 3 receptors and store-operated Htrp3 channels
8. 2+ entry: Evidence for a secretion-like coupling model
9. A novel type of cardiac calcium channel in ventricular cells
10. Two kinds of calcium channels in canine atrial cells. Differences in kinetics, selectivity, and pharmacology
11. Structure and function of voltage-gated ion channels
12. The roles of the subunits in the function of the calcium channel
13. 2+ channels
14. 2+ channel gamma subunit genes reveals molecular diversification by tandem and chromosome duplication
15. Nomenclature of voltage-gated calcium channels
16. 2+ channel alpha 2 delta subunit in current stimulation and subunit interaction
17. Importance of the different beta subunits in the membrane expression of the alpha1 A and alpha2 calcium channel subunits: Studies using a depolarization-sensitive alpha1 A antibody
18. From worm to man: Three subfamilies of TRP channels
19. Calcium channels formed by mammalian Trp homologues
20. Capacitative calcium entry channels
21. Properties of heterologously expressed hTRP3 channels in bovine pulmonary artery endothelial cells
22. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol
23. 2+ channels
24. Depletion of intracellular calcium stores activates a calcium current in mast cells
25. Rapid inactivation of depletion-activated calcium current (ICRAC) due to local calcium feedback
26. Store depletion triggers the calcium release-activated calcium current (ICRAC) in macrovascular endothelial cells: A comparison with Jurkat and embryonic kidney cell lines
27. Peripheral and central actions of capsaicin and VR1 receptor
28. Capsaicin-receptor homologue with a high threshold for noxious heat
29. Molecular cloning of an N-terminal splice variant of the capsaicin receptor. Loss of N-terminal domain suggests functional divergence among capsaicin receptor subtypes
30. 3-responsive epithelia
31. Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption
32. Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I
33. 2+ channel
34. Osm-9, a novel protein with structural similarity to channels, is required for olfaction, mechanosensation and olfactory adaptation in Caenorhabditis elegans
35. Intracellular calcium homeostasis
36. The plasma membrane calcium pump: Recent developments and future perspectives
37. Sodium/calcium exchange: Its physiological implications
38. The plasma membrane calcium pump: Functional domains, regulation of the activity, and tissue specificity of isoform expression
39. The calcium pump of the plasma membrane: Membrane targeting, calcium binding sites, tissue-specific isoform expression
40. Sodium-calcium exchange: Recent advances
41. Molecular and cellular physiology of intracellular calcium stores
42. Inositol phosphates and cell signaling
43. 2+ signaling
44. 2+ dependence of inositol 1,4,5-trisphosphate-induced Ca release in smooth muscle cells of the guinea pig taenia caeci
45. 3- and calcium-gated channels from endoplasmic reticulum of cerebellum
46. 2+ in permeabilized cells
47. 2+/calmodulin
48. Calmodulin mediates calcium-dependent inactivation of the cerebellar type 1 inositol 1,4,5-trisphosphate receptor
49. 2+ release channel
50. 2+ release channels and their regulation of endogenous effectors
51. 2+ release channels: Does diversity in form equal diversity in function?
52. 2+-release channel function
53. Potential for pharmacology of ryanodine receptor/calcium release channels
54. Functional comparisons between isoforms of the sarcoplasmic or endoplasmic reticulum family of calcium pumps
55. 2+-ATPase of cardiac sarcoplasmic reticulum are critical for functional association with phospholamban
56. A survey of the interaction of calcium ions with mitochondria from different tissues and species
57. 3-sensitive channels that are sensed by neighboring mitochondria
58. Mitochondrial calcium transport: Physiological and pathological relevance
59. High tide of calcium in mitochondria
60. 2+ store, with functional properties distinct from those of the endoplasmic reticulum
61. Calcium - A life and death signal
62. The elemental principles of calcium signaling
63. Cooking with calcium: The recipes for composing global signals from elementary events
64. Relaxation of arterial smooth muscle by calcium sparks
65. 2+ as evidenced in single pancreatic islets
66. Calcium oscillations increase the efficiency and specificity of gene expression
67. 2+ spikes regulating distinct cellular functions in pancreatic acinar cells
68. 2+ response amplitude and duration
69. Ryanodine receptors of striated muscles: A complex channel capable of multiple interactions
70. 2+ release channels
71. Malignant hyperthermia
72. Malignant hyperthermia
73. Malignant hyperthermia myopathy
74. 2+ regulation defects
75. Genetics and pathogenesis of malignant hyperthermia
76. Ryanodine receptor mutations in malignant hyperthermia and central core disease
77. A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia
78. 2+ channel regulation
79. 2+ release channels
80. Calcium release from skeletal muscle sarcoplasmic reticulum: Site of action of dantrolene sodium
81. Dantrolene in human malignant hyperthermia
82. 31P-NMR spectroscopy: The metabolic profile of malignant hyperpyrexia porcine skeletal muscle
83. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia
84. Etiopathogenetic defect of malignant hyperthermia: Hypersensitive calcium-release channel of skeletal muscle sarcoplasmic reticulum
85. A new congenital non-progressive myopathy
86. Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia
87. A mutation in the human ryanodine receptor associated with central core disease
88. Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: Novel mutations and concordance with the in vitro contracture test
89. 2+ release channel function and severe central core disease
90. 2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease
91. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma
92. Anti-cardiac ryanodine receptor antibodies in thymoma-associated myasthenia gravis
93. Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene
94. Functional nonequality of the cardiac and skeletal ryanodine receptors
95. 2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor
96. Failure to make normal alpha ryanodine receptor is an early event associated with the crooked neck dwarf (cn) mutation in chicken
97. Embryonic chicken skeletal muscle cells fail to develop normal excitation-contraction coupling in the absence of the α ryanodine receptor. Implications for a two ryanodine receptor system
98. Generation and characterization of mutant mice lacking ryanodine receptor type 3
99. Requirement of the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles
100. 2+ sparks in embryonic mouse skeletal muscle
101. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis
102. A calcium channel mutation causing hypokalemic periodic paralysis
103. Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis
104. Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle
105. Localization of the gene encoding the alpha 2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families
106. A single nucleotide deletion in the skeletal muscle-specific calcium channel transcript of muscular dysgenesis (mdg) mice
107. A lethal mutation in mice eliminates the slow calcium current in skeletal muscle cells
108. Absence of the beta subunit (cchb 1) of the skeletal muscle dihydropyridine receptor alters expression of the alpha 1 subunit and eliminates excitation-contraction coupling
109. 2+ transients in skeletal muscle deficient in dihydropyridine receptor beta 1 subunit
110. 2+ sparks in embryonic mouse skeletal muscle selectively deficient in dihydropyridine receptor alpha 1S or beta 1a subunits
111. Muscle contracture induced by exercise. A syndrome attributable to decreased relaxing factor
112. 2+ ATPase, are associated with Brody disease
113. Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: Absence of structural mutations in five patients with Brody disease
114. 2+-binding and translocation domain of SERCA1: Physiological correlates in Brody disease
115. Dependence of epithelial intercellular junction biogenesis on thapsigargin-sensitive intracellular calcium stores
116. Bumps and pumps, SERCA 1999
117. 2+ pump, cause Darier disease
118. Spectrum of novel ATP2A2 mutations in patients with Darier's disease
119. ATP2A2 mutations in Darier's disease: Variant cutaneous phenotypes are associated with missense mutations, but neuropsychiatric features are independent of mutation class
120. Mutations in ATP2CI, encoding a calcium pump, cause Hailey-Hailey disease
121. 2+ pump
122. An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness
123. Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness
124. A Drosophila calcium channel alpha 1 subunit gene maps to a genetic locus associated with behavioral and visual defects
125. 2+ mobilization
126. 2+ and trp
127. Molecular characterization of the Drosophila trp locus: A putative integral membrane protein required for phototransduction
128. Identification of a Drosophila gene encoding a calmodulin-binding protein with homology to the trp phototransduction gene
129. Novel mechanism of massive photoreceptor degeneration caused by mutations in the trp gene of Drosophila
130. Ion channel genes and human neurological disease: Recent progress, prospects, and challenges
131. Voltage-dependent calcium channel mutations in neurological disease
132. Calcium channelopathies in the central nervous system
133. Calcium channelopathies
134. Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia
135. Primary structure and functional expression from complementary DNA of a brain calcium channel
136. Immunochemical identification and subcellular distribution of the alpha 1A subunits of brain calcium channels
137. Voltage-gated ion channels and hereditary disease
138. 2+ channel kinetics
139. Progressive ataxia due to a missense mutation in a calcium-channel gene
140. 2+ channel gene CACNL1A4
141. De novo mutation in CACNA1A caused acetazolamide-responsive episodic ataxia
142. High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2
143. A novel nonsense mutation in CACNA1A causes episodic ataxia and hemiplegia
144. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel
145. SCA6 is caused by moderate CAG expansion in the alpha 1A-voltage-dependent calcium channel gene
146. Spinocerebellar ataxia type 6 mutation alters P-type calcium channel function
147. Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia
148. A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia
149. Genetic heterogeneity in Italian families with familial hemiplegic migraine
150. 2+ channel kinetics
151. Functional consequences of mutations in the human alpha 1 A calcium channel subunit linked to familial hemiplegic migraine
152. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p
153. Absence epilepsy in tottering mutant mice is associated with calcium channel defects
154. L-type calcium channels contribute to the tottering mouse dystonic episodes
155. Altered calcium channel currents in Purkinje cells of the neurological mutant mouse leaner
156. Single tottering mutations responsible for the neuropathic phenotype of the P-type calcium channel
157. 2+ channel beta subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (1h) mouse
158. Altered expression and assembly of N-type calcium channel alpha-1B and beta subunits in epileptic lethargic (1h/1h) mouse
159. 2+ channel subunit compositions in lethargic mouse brain
160. 2+-channel gamma subunit
161. Mouse models of spike-wave epilepsy
162. IgG from patients with Lamber-Eaton syndrome blocks voltage-dependent calcium channels
163. 2+ flux in a human small cell carcinoma line
164. Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons
165. Recombinant calcium channel is recognized by Lambert-Eaton myasthenic syndrome antibodies
166. Lambert-Eaton myasthenic syndrome as an autoimmune calcium-channelopathy
167. Antibodies against the beta subunit of voltage-dependent calcium channels in Lambert-Eaton myasthenic syndrome
168. Incidence of serum anti-P/Q type and anti-N type calcium channel auto-antibodies in the Lambert-Eaton myasthenic syndrome
169. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse
170. Reduction of calcium currents by Lambert-Eaton syndrome sera: Motoneurons are preferentially affected, and L-type currents are spared
171. 2+ channel alpha 1 subunit
172. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis
173. 2+ currents in a motoneuron cell line
174. Calcium current and charge movement of mammalian muscle: Action of amyotrophic lateral sclerosis immunoglobulins
175. Immunoassays fail to detect antibodies against-neuronal calcium channels in amyotrophic lateral sclerosis serum
176. Amyotrophic lateral sclerosis and antibodies to voltage-gated calcium channels-new doubts
177. Genetic and developmental characterization of Dmca1D, a calcium channel alpha1 subunit gene in Drosophila melanogaster
178. Courtship and visual defects of cacophony mutants reveal functional complexity of a calcium-channel alpha1 subunit in Drosophila
179. 2+-ATPase isoform 2
180. 2+-ATPase gene cause deafness in deafwaddler mice
181. 2+-ATPase gene causes deafness in Wriggle Mouse Sagami
182. ATP2A2 mutations in Darier's disease and their relationship to neuropsychiatric phenotypes
183. The type 1 inositol 1,4,5-trisphosphate receptor gene is altered in the opisthotonos mouse
184. Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor
185. Calcium signaling molecules in human cerebellum at midgestation and in ataxia
186. Deletion of the ryanodine receptor type 3 (RyR3) impairs forms of synaptic plasticity and spatial learning
187. Mutant mice lacking ryanodine receptor type 3 exhibit deficits of contextual fear conditioning and activation of calcium/calmodulin-dependent protein kinase II in the hippocampus
188. Embryonic lethality and abnormal cardiac myocytes in mice lacking ryanodine receptor type 2
189. Neural and developmental actions of lithium: A unifying hypothesis
190. Inhibition of the high affinity myoinositol transport system: A common mechanism of action of antibipolar drugs?
191. Neurobiology of lithium: An update
192. Synaptic defects and compensatory regulation of inositol metabolism in inositol polyphosphate 1-phosphatase mutants
193. Alzheimer's PS-1 mutation perturbs calcium homeostasis- and sensitizes PC12 cells to death induced by amyloid beta-peptide
194. Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: Reduced oxidative stress and preserved mitochondrial function
195. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice
196. Calcium ionophore increases amyloid beta peptide production by cultured cells
197. Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cortical neurons
198. Presenilin-2 mutations modulate amplitude and kinetics of inositol 1,4,5-trisphosphate-mediated calcium signals
199. Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes
200. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons
201. Presenilin 2 interacts with sorcin, a modulator of the ryanodine receptor
202. Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: Involvement of perturbed calcium homeostasis
203. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice
204. Organic aciduria, decreased renal ammonia production, hydrophtalmos, and mental retardation: A clinical entity
205. The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase
206. The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase
207. Lowe syndrome, a deficiency of phosphatidylinositol 4,5-bisphosphate 5-phosphatase in the Golgi apparatus
208. Excitation-contraction coupling in mammalian cardiac cells
209. Calcium sparks: Release packets of uncertain origin and fundamental role
210. Molecular mechanisms of myocardial remodeling
211. 2+-dependent adenosine triphosphatase from rat cardiac sarcoplasmic reticulum. Regulation of its expression by pressure overload and developmental stage
212. 2+ transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure
213. Sarcoplasmic reticulum gene expression in pressure overload-induced cardiac hypertrophy in rabbit
214. 2+-ATPase during progression of left ventricular hypertrophy
215. 2+-ATPase gene expression in the human ventricle during end-stage heart failure
216. 2+-ATPase in failing and nonfailing human myocardium
217. Effects of inhibition of sarcoplasmic reticulum calcium uptake on contraction in myocytes isolated from failing human ventricle
218. 2+ transients
219. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure
220. Prospects for gene therapy for heart failure
221. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy
222. 2+-ATPase isoform 2 (SERCA2) gene
223. 2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation
224. The effects of compensated cardiac hypertrophy on dihydropyridine and ryanodine receptors in rat, ferret and guinea-pig hearts
225. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure
226. Phosphatidylinositol metabolism in hypertrophic rat heart
227. Differential regulation of two types of intracellular calcium release channels during end-stage heart failure
228. 2+ exchange activity in cardiomyopathic Syrian hamster
229. 2+ exchanger in end-stage human heart failure
230. 2+ exchanger in failing human myocardium
231. A novel FK506 binding protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor
232. Neural actions of immunophilin ligands
233. Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients
234. Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12
235. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): Defective regulation in failing hearts
236. 2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin
237. Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice
238. Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression
239. Regulation of GATA-4 and AP-1 in transgenic mice overexpressing cardiac calsequestrin
240. Aging of the cardiovascular system
241. Human SERCA2a levels correlate inversely with age in senescent human myocardium
242. 2+-ATPase
243. Abnormal platelet and lymphocyte calcium handling in prehypertensive rats
244. 2+-ATPases: Specific upregulation of the 97 kDa isoform
245. 2+-ATPase isoform 3
246. 2+ is important for the proteolytic processing and intracellular transport of proinsulin in the pancreatic beta-cell
247. 2+-ATPase are differentially expressed in normal and diabetic islets of Langerhans
248. Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes
249. 2+-transport ATPase 3 gene (SERCA3) in caucasian type II diabetic patients (UK prospective diabetes study 48)